Annexin Pharmaceuticals AB (ANNX) — Strategic Asset Allocation Index
Annexin Pharmaceuticals AB (ANNX) has a Strategic Asset Allocation Index of 4.5% as of December 2025. Strategic assets (PP&E of Skr1.12 Million plus long-term investments of Skr-) total Skr1.12 Million, measured against net assets of Skr24.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Annexin Pharmaceuticals AB Strategic Asset Allocation Index (2017–2025)
This chart shows how Annexin Pharmaceuticals AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 4.5%, representing strategic assets of Skr1.12 Million against net assets of Skr24.93 Million SEK. Explore ANNX cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Annexin Pharmaceuticals AB (2017–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Annexin Pharmaceuticals AB from 2017 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Annexin Pharmaceuticals AB (ANNX) market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.5% | Skr1.12 Million | Skr1.12 Million | Skr- | Skr24.93 Million | ▼ -3.4 pp |
| 2024 | 7.8% | Skr1.08 Million | Skr1.08 Million | Skr- | Skr13.71 Million | ▲ +1.6 pp |
| 2023 | 6.2% | Skr1.17 Million | Skr1.17 Million | Skr- | Skr18.81 Million | ▲ +2.0 pp |
| 2022 | 4.2% | Skr1.26 Million | Skr1.26 Million | Skr- | Skr30.15 Million | ▲ +1.3 pp |
| 2021 | 2.9% | Skr1.35 Million | Skr1.35 Million | Skr- | Skr46.73 Million | ▼ -4.1 pp |
| 2020 | 7.0% | Skr1.44 Million | Skr1.44 Million | Skr- | Skr20.64 Million | ▼ -6.3 pp |
| 2019 | 13.3% | Skr1.52 Million | Skr1.52 Million | Skr- | Skr11.49 Million | ▲ +9.2 pp |
| 2018 | 4.1% | Skr1.61 Million | Skr1.61 Million | Skr- | Skr39.85 Million | ▼ -2.9 pp |
| 2017 | 7.0% | Skr1.70 Million | Skr1.70 Million | Skr- | Skr24.44 Million | — |